Stengone Carmine N.
CEO and President · 11 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | CTNM | Contineum Therapeutics, Inc. | Sale | 2,500 | $16.00 | $40,000.00 | filing |
| 2026-07-08 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 2,500 | $1.01 | $2,525.00 | filing |
| 2026-06-30 | CTNM | Contineum Therapeutics, Inc. | Sale | 10,000 | $16.01 | $160,080.00 | filing |
| 2026-06-30 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 7,500 | $1.01 | $7,575.00 | filing |
| 2026-06-30 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 2,500 | $1.26 | $3,150.00 | filing |
| 2026-02-25 | CTNM | Contineum Therapeutics, Inc. | Sale | 2,700 | $16.02 | $43,241.85 | filing |
| 2026-02-25 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 2,700 | $1.26 | $3,402.00 | filing |
| 2026-02-24 | CTNM | Contineum Therapeutics, Inc. | Sale | 4,400 | $16.02 | $70,485.80 | filing |
| 2026-02-24 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 4,400 | $1.26 | $5,544.00 | filing |
| 2026-02-11 | CTNM | Contineum Therapeutics, Inc. | Sale | 400 | $16.00 | $6,400.00 | filing |
| 2026-02-11 | CTNM | Contineum Therapeutics, Inc. | Option exercise | 400 | $1.26 | $504.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.